Way to reduce Rituximab effect found

Way to reduce rituximab effect found

Each year, 3,500 Taiwanese get lymphoma, and 60% of them are placed on rituximab chemotherapy.

Rituximab activates hepatitis B virus and leads to acute hepatitis and acute liver failure.

Proactive intake of preventative hepatitis B antiviral drugs before administration of rituximab for lymphoma reduces the 55% revival rate due to rituximab therapy down to 2.5% recurrence.

At present, there are 1,234 lymphoma patients who are hepatitis B sufferers.

This report can be found in the June 2019 edition of the Journal of the Formosan Medical Association.

 

About masterchensays

Victor Chen, herbalist, alternative healthcare lecturer, Chinese affairs analyst, retired journalist
This entry was posted in Uncategorized. Bookmark the permalink.